Steven J. Lester

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

A simple method for noninvasive estimation of pulmonary vascular resistance

Amr E. Abbas, F. David Fortuin, Nelson B. Schiller et al. · Journal of the American College of Cardiology · 2003 · 639 citations

Pulmonary Vascular Resistance, Pulmonary Arterial Hypertension, Pulmonary Circulation +10

Best method in clinical practice and in research studies to determine left atrial size

Steven J. Lester, Elizabeth W. Ryan, Nelson B. Schiller et al. · The American Journal of Cardiology · 1999 · 539 citations

Electrophysiological Evaluation, Heart Failure, Radiology +11

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy

Carolyn Y. Ho, Matthew E. Mealiffe, Richard G. Bach et al. · Journal of the American College of Cardiology · 2020 · 316 citations · Full text

Usefulness of Left Atrial Volume in Predicting First Congestive Heart Failure in Patients ≥65 Years of Age With Well-Preserved Left Ventricular Systolic Function

Yasuhiko Takemoto, Marion E. Barnes, James B. Seward et al. · The American Journal of Cardiology · 2005 · 312 citations

Heart Failure, Cardiovascular Disease, Cardiac Mechanic +8